SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-003689
Accepted
2023-12-20 00:15:23
Documents
1
Effectiveness Date
2023-12-19
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-23-003689.txt   1790
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-275958 | Film No.: 231499219
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)